You are here



Cardiovascular disease’s “obesity paradox”—the idea that being dangerously overweight can improve end-of-life survival in heart patients—was recently debunked by a team of researchers in New York and Michigan, finding the claim to be untrue for those with incident heart disease.

A secondary analysis of the decades-old DASH-Sodium trial found the popular DASH diet, combined with a reduced sodium intake, successfully lowered systolic blood pressure in a hypertension-prone population, according to a new study published in the Journal of the American College of Cardiology.

Patients with atrial fibrillation (AFib) who are admitted to rural hospitals have a 17 percent increased risk of death during their stay compared to those admitted to urban facilities, researchers reported in HeartRhythm.

A recent article in Cardiovascular Business summarized the lack of quality research on surgeries for children with congenital heart disease. Finding participants isn't the problem; study design and execution are at fault.

A majority of patients who undergo bariatric surgery for the first time maintain significant weight loss through seven years of follow-up, according to a study published Dec. 6 in JAMA Surgery.